Trial Profile
A Study Evaluating the Safety and Efficacy of Bivalirudin in the Management of Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary PCI (BIAMI)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary)
- Indications Embolism and thrombosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms BIAMI
- 09 Oct 2005 New trial record.